Autolus Therapeutics plc Other Current Assets
Autolus Therapeutics plc (AUTL) had Other Current Assets of $0 as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-03-27
- 2025-12-31: Other Assets, Current $0.00.
- 2025-06-30: Other Assets, Current $0.00.
- 2025-03-31: Other Assets, Current $1.62M.
- 2024-12-31: Other Assets, Current $1.57M.
| Period end | Other Assets, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-27 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.62M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.57M 10-K · filed 2026-03-27 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 |
| 2023-09-30 | $127.00K 10-Q · filed 2023-11-09 |
| 2022-12-31 | $203.00K 10-K · filed 2024-03-21 |
| 2021-12-31 | $240.00K 20-F · filed 2023-03-07 |
| 2020-12-31 | $0.00 20-F · filed 2022-03-10 |
| 2020-09-30 | $988.00K 6-K · filed 2020-11-05 |
| 2020-06-30 | $247.00K 6-K · filed 2020-08-06 |
| 2020-03-31 | $334.00K 6-K · filed 2020-05-07 |
| 2019-12-31 | $279.00K 20-F · filed 2021-03-04 |
| 2018-12-31 | $0.00 20-F · filed 2020-03-03 |
| 2018-09-30 | $717.00K 20-F · filed 2019-02-25 |
| 2017-09-30 | $0.00 20-F · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 |